FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034303073> ?p ?o ?g. }

• W2034303073 endingPage "1620" @default.
• W2034303073 startingPage "1614" @default.
• W2034303073 abstract "Background MKC-1 is an orally available cell cycle inhibitor with downstream targets that include tubulin and the importin-β family. We conducted an open-label Phase II study with MKC-1 in patients with advanced pancreatic cancer. Methods Eligibility criteria included unresectable or metastatic pancreatic cancer, performance status of 1 or better, and failure of at least one prior regimen of chemotherapy. MKC-1 was administered orally, twice daily, initially at 100 mg/m2 dosing for 14 consecutive days of a 28-day cycle. This schedule was modified during the trial to fixed and continuous dosing of 150 mg per day. Results 20 of an original target of 33 patients were accrued, with a median age of 61 (range 44–81). No objective responses were observed, with one patient demonstrating stable disease. Overall survival was 101 days from the start of MKC-1 administration, and median time to progression was 42 days. The most common adverse events listed as related or possibly related to MKC-1 administration were hematologic toxicities and fatigue. One patient developed grade 5 (fatal) pancytopenia. Grade 3 and 4 events included cytopenias (lymphopenia, anemia), hyperbilirubinemia, pneumonia, mucositis, fatigue, infusion reaction, anorexia, and hypoalbuminemia. Conclusions MKC-1 administration was associated with substantial toxicity and did not demonstrate sufficient activity in patients with advanced pancreatic cancer to justify further exploration in this patient population." @default.
• W2034303073 created "2016-06-24" @default.
• W2034303073 creator A5007574547 @default.
• W2034303073 creator A5015900819 @default.
• W2034303073 creator A5027091100 @default.
• W2034303073 creator A5045494904 @default.
• W2034303073 creator A5047496278 @default.
• W2034303073 creator A5056060963 @default.
• W2034303073 creator A5070720153 @default.
• W2034303073 creator A5075625649 @default.
• W2034303073 creator A5077382664 @default.
• W2034303073 creator A5081543892 @default.
• W2034303073 creator A5088474933 @default.
• W2034303073 creator A5090604653 @default.
• W2034303073 date "2011-07-29" @default.
• W2034303073 modified "2023-09-24" @default.
• W2034303073 title "A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer" @default.
• W2034303073 cites W14333088 @default.
• W2034303073 cites W1931508686 @default.
• W2034303073 cites W1985483877 @default.
• W2034303073 cites W2061271254 @default.
• W2034303073 cites W2121120744 @default.
• W2034303073 cites W2123344367 @default.
• W2034303073 cites W2129056290 @default.
• W2034303073 cites W2131709903 @default.
• W2034303073 cites W2151253787 @default.
• W2034303073 cites W2162651519 @default.
• W2034303073 cites W2163762497 @default.
• W2034303073 cites W2260342693 @default.
• W2034303073 cites W4297819854 @default.
• W2034303073 doi "https://doi.org/10.1007/s10637-011-9708-3" @default.
• W2034303073 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3670147" @default.
• W2034303073 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21800081" @default.
• W2034303073 hasPublicationYear "2011" @default.
• W2034303073 type Work @default.
• W2034303073 sameAs 2034303073 @default.
• W2034303073 citedByCount "7" @default.
• W2034303073 countsByYear W20343030732013 @default.
• W2034303073 countsByYear W20343030732014 @default.
• W2034303073 countsByYear W20343030732015 @default.
• W2034303073 countsByYear W20343030732016 @default.
• W2034303073 countsByYear W20343030732019 @default.
• W2034303073 crossrefType "journal-article" @default.
• W2034303073 hasAuthorship W2034303073A5007574547 @default.
• W2034303073 hasAuthorship W2034303073A5015900819 @default.
• W2034303073 hasAuthorship W2034303073A5027091100 @default.
• W2034303073 hasAuthorship W2034303073A5045494904 @default.
• W2034303073 hasAuthorship W2034303073A5047496278 @default.
• W2034303073 hasAuthorship W2034303073A5056060963 @default.
• W2034303073 hasAuthorship W2034303073A5070720153 @default.
• W2034303073 hasAuthorship W2034303073A5075625649 @default.
• W2034303073 hasAuthorship W2034303073A5077382664 @default.
• W2034303073 hasAuthorship W2034303073A5081543892 @default.
• W2034303073 hasAuthorship W2034303073A5088474933 @default.
• W2034303073 hasAuthorship W2034303073A5090604653 @default.
• W2034303073 hasBestOaLocation W20343030732 @default.
• W2034303073 hasConcept C121608353 @default.
• W2034303073 hasConcept C126322002 @default.
• W2034303073 hasConcept C143998085 @default.
• W2034303073 hasConcept C197934379 @default.
• W2034303073 hasConcept C2776694085 @default.
• W2034303073 hasConcept C2777288759 @default.
• W2034303073 hasConcept C2778248108 @default.
• W2034303073 hasConcept C2778496288 @default.
• W2034303073 hasConcept C2780210213 @default.
• W2034303073 hasConcept C2781413609 @default.
• W2034303073 hasConcept C29730261 @default.
• W2034303073 hasConcept C31760486 @default.
• W2034303073 hasConcept C71924100 @default.
• W2034303073 hasConcept C90924648 @default.
• W2034303073 hasConceptScore W2034303073C121608353 @default.
• W2034303073 hasConceptScore W2034303073C126322002 @default.
• W2034303073 hasConceptScore W2034303073C143998085 @default.
• W2034303073 hasConceptScore W2034303073C197934379 @default.
• W2034303073 hasConceptScore W2034303073C2776694085 @default.
• W2034303073 hasConceptScore W2034303073C2777288759 @default.
• W2034303073 hasConceptScore W2034303073C2778248108 @default.
• W2034303073 hasConceptScore W2034303073C2778496288 @default.
• W2034303073 hasConceptScore W2034303073C2780210213 @default.
• W2034303073 hasConceptScore W2034303073C2781413609 @default.
• W2034303073 hasConceptScore W2034303073C29730261 @default.
• W2034303073 hasConceptScore W2034303073C31760486 @default.
• W2034303073 hasConceptScore W2034303073C71924100 @default.
• W2034303073 hasConceptScore W2034303073C90924648 @default.
• W2034303073 hasIssue "4" @default.
• W2034303073 hasLocation W20343030731 @default.
• W2034303073 hasLocation W20343030732 @default.
• W2034303073 hasLocation W20343030733 @default.
• W2034303073 hasLocation W20343030734 @default.
• W2034303073 hasOpenAccess W2034303073 @default.
• W2034303073 hasPrimaryLocation W20343030731 @default.
• W2034303073 hasRelatedWork W1982603734 @default.
• W2034303073 hasRelatedWork W2010083182 @default.
• W2034303073 hasRelatedWork W2024219304 @default.
• W2034303073 hasRelatedWork W2316688895 @default.
• W2034303073 hasRelatedWork W2365983310 @default.
• W2034303073 hasRelatedWork W2375012438 @default.
• W2034303073 hasRelatedWork W2388730008 @default.

• next